Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 250 of 3173 entries
View as:

A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation

Phase: N/A Priority: Normal
NCT ID: NCT02310750 Org: User:
Start: 11/30/14 End: 02/29/16 Due: 02/28/17

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Phase: N/A Priority: Normal
NCT ID: NCT05732454 Org: User:
Start: 01/18/23 End: 04/29/24 Due: 04/29/25

A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01458574 Org: User:
Start: 07/20/12 End: 05/27/16 Due: 05/27/17

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03642847 Org: User:
Start: 08/29/18 End: 03/29/19 Due: 03/29/20

Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01244880 Org: User:
Start: 04/30/11 End: 08/31/12 Due: 08/31/13

A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01712061 Org: User:
Start: 12/31/12 End: 09/30/14 Due: 09/30/15

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Phase: N/A Priority: Normal
NCT ID: NCT00002277 Org: User:
Start: - End: - Due: -

An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02883114 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

Phase: N/A Priority: Normal
NCT ID: NCT05794191 Org: User:
Start: 03/22/23 End: 08/15/24 Due: 08/15/25

Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00827502 Org: User:
Start: 02/28/09 End: 07/31/09 Due: 07/31/10

Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT03943615 Org: User:
Start: - End: - Due: -

Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT03021941 Org: User:
Start: 07/31/19 End: 06/30/20 Due: 06/30/21

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Phase: N/A Priority: Normal
NCT ID: NCT00138749 Org: User:
Start: 11/30/04 End: 08/31/06 Due: 08/31/07

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01786668 Org: User:
Start: 04/30/13 End: 03/31/15 Due: 03/31/16

Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04388878 Org: User:
Start: 07/27/20 End: 06/21/22 Due: 06/21/23

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02159066 Org: User:
Start: 07/23/14 End: 01/10/23 Due: 01/10/24

Evaluate Severe Hepatic Impairment on Dacomitinib PK

Phase: N/A Priority: Normal
NCT ID: NCT03865446 Org: User:
Start: 04/05/19 End: 10/24/19 Due: 10/24/20

Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)

Phase: N/A Priority: Normal
NCT ID: NCT02349633 Org: User:
Start: 05/14/15 End: 05/28/20 Due: 05/28/21

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Phase: N/A Priority: Normal
NCT ID: NCT06199934 Org: User:
Start: 02/07/24 End: 07/31/24 Due: 07/31/25

A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05733104 Org: User:
Start: 02/19/24 End: 09/28/29 Due: 09/28/30

Asian Phase I Study Of PF-03446962

Phase: N/A Priority: Normal
NCT ID: NCT01337050 Org: User:
Start: 07/31/11 End: 03/31/14 Due: 03/31/15

Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT01032174 Org: User:
Start: 04/30/10 End: 03/31/11 Due: 03/31/12

A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02184429 Org: User:
Start: 07/31/14 End: 03/31/15 Due: 03/31/16

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00821249 Org: User:
Start: 01/31/09 End: 03/16/16 Due: 03/16/17

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Phase: N/A Priority: Normal
NCT ID: NCT01213823 Org: User:
Start: 09/30/08 End: 05/31/11 Due: 05/31/12